Arden Trust’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,310
Closed -$252K 304
2021
Q2
$252K Buy
9,310
+226
+2% +$6.32K 0.04% 277
2021
Q1
$272K Sell
9,084
-2,003
-18% -$68.3K 0.05% 271
2020
Q4
$319K Sell
11,087
-2,224
-17% -$60K 0.05% 244
2020
Q3
$325K Sell
13,311
-1,710
-11% -$36.9K 0.06% 232
2020
Q2
$269K Buy
15,021
+328
+2% +$4.31K 0.05% 263
2020
Q1
$120K Buy
14,693
+37
+0.3% +$423 0.02% 358
2019
Q4
$194K Buy
+14,656
New +$177K 0.03% 338

Other funds holding CVET

Arden Trust's CVET Position: Q3 2021 in Review

Arden Trust sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2021, closing a stake of 9,310 shares — an estimated $252K sold.

Arden Trust first reported a position in CVET in Q4 2019 and held it in 7 quarters. The position peaked at $325K in Q3 2020. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

  • Arden Trust reported no remaining Covetrus, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Arden Trust sold 9,310 Covetrus, Inc. Common Stock shares in Q3 2021, an estimated $252K.
  • Arden Trust first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Arden Trust's Covetrus, Inc. Common Stock position peaked at $325K in Q3 2020.
  • 260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on Arden Trust's 13F filing for Q3 2021, filed 12 Oct 2021.